Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × toripalimab × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Neoplasm Metastasis 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Muscle Invasive Bladder Cancer (MIBC) 1 Mouth Neoplasms 1 Melanoma 1 Local Advanced Non-small Cell Lung Cancer 1 Laryngeal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Malignant Solid Tumors 1 Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 4 Platinum 3 Pemetrexed 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 tremelimumab 1 methoxyamine 1 decitabine and cedazuridine drug combination 1 cediranib 1 atezolizumab 1 aldesleukin 1 Radiotherapy 1 Radiation 1 Pharmaceutical Preparations 1 Nivolumab 1 Ipilimumab 1 Interleukin-2 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1 Cyclophosphamide 1 Carboplatin 1 Bevacizumab 1 BAY 1895344 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡